Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Most patients prefer clinics that play music during procedures.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Linalool in fragrances may harm hair follicles and contribute to hair loss.

The Fas/FasL pathway may play a role in alopecia areata.

Higher blood sugar levels may lead to more severe hair loss in women.

Low-dose spironolactone can be effective for treating hair loss in women.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Alopecia is a condition causing hair loss that can impact looks and mental health.

Gabapentin helps with scalp itch, dutasteride works for frontal fibrosing alopecia, and more research is needed for better PCA treatments.

Patients were highly satisfied with shared medical appointments for hair loss treatment.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Platelet-rich plasma may help with hair loss from androgenetic alopecia.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

CTP-543 is generally safe for treating alopecia areata.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.